By Liana Fattore
The applying of hashish sativa for the remedy of neurologic and psychological affliction is increasing. Cannabinoids in Neurologic and psychological Disease collects and offers for the 1st time contemporary examine concerning using pharmacological cannabinoids for the remedy of neurodegenerative and neuroinflammatory disorder. The neurologic program of cannabinoid treatment builds upon psychiatric and mental use for the remedy of quite a few center psychological issues. This finished reference at the identified makes use of of cannabinoids can be beneficial for scientific neurologists, neuroscience and scientific neuroscience researchers, scientific psychologists and psychiatrists and the overall scientific community.
- A complete reference at the medical makes use of of cannabinoids for treating significant neurologic and psychological diseases
- Detailed assurance of cannabinoid use for neuroinflammatory and neurodegenerative disorder together with a number of Sclerosis, Epilepsy, Huntington's disorder, Parkinson's illness, and Alzheimer's disease
- Detailed insurance of cannabinoid use for significant psychiatric and mental illnesses and issues together with schizophrenia, bipolar problems, Tourette's syndrome, and post-traumatic tension disease (PTSD)
Read Online or Download Cannabinoids in Neurologic and Mental Disease PDF
Similar neuroscience books
Using animal types is a key point of clinical examine in several fields of drugs. This e-book vigorously examines the real contributions and alertness of animal types to the certainty of human stream issues and may function an important source for simple neuroscientists engaged in stream issues learn.
Epilepsy, some of the most ordinary neurological issues, impacts nearly 1% (greater than 60 million) of the world's inhabitants. In an predicted 20 million of those sufferers, seizures aren't managed even by way of a number of anti-seizure medications, and are super tough to foretell. Epilepsy: The Intersection of Neurosciences, Biology, arithmetic, Engineering, and Physics seamlessly brings jointly the neurosciences, arithmetic, computational sciences, engineering, physics, and scientific epileptology to offer to readers a hugely didactic, built-in, transparent and essentially important wisdom base and study instructions.
- Pieces of Mind: 21 Short Walks Around the Human Brain
- The Behavioral Neurology of White Matter
- Pathological Potential of Neuroglia: Possible New Targets for Medical Intervention
- Electroporation Methods in Neuroscience
- Brain-Wise: Studies in Neurophilosophy
Extra info for Cannabinoids in Neurologic and Mental Disease
The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine. Prostaglandins Leukot. Essent. Fatty Acids 81, 291À301. , 2001. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J. Biol. Chem. 276, 42639À42644. , 2002. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl Acad.
2006. A FAAH-regulated class of N-acyl taurines that activates TRP ion channels. Biochemistry 45, 9007À9015. , 1996. The N-acylation-phosphodiesterase pathway and cell signalling. Chem. Phys. Lipids 80, 133À142. , 2013. Anandamide-derived prostamide F2alpha negatively regulates adipogenesis. J. Biol. Chem. 288, 23307À23321. , 2008. Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J. Biol. Chem. 283, 9341À9349.
Development of the first potent and specific inhibitors of endocannabinoid biosynthesis. Biochim. Biophys. Acta 1761, 205À212. , 2007. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 14, 1347À1356. , 1995. Microsomal cytochrome P450-mediated liver and brain anandamide metabolism. Biochem. Pharmacol. 50, 677À686. , 2000. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol.
Cannabinoids in Neurologic and Mental Disease by Liana Fattore